Tonix Pharmaceuticals Holding Corp.
TNXP
$15.52
$0.301.97%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -99.22M | -81.42M | -131.93M | -130.04M | -135.25M |
| Total Depreciation and Amortization | 2.41M | 2.46M | 2.88M | 3.40M | 3.92M |
| Total Amortization of Deferred Charges | -211.00K | -2.00K | 427.00K | 864.00K | 902.00K |
| Total Other Non-Cash Items | 11.03M | 10.20M | 67.36M | 59.08M | 62.07M |
| Change in Net Operating Assets | 11.17M | 3.93M | 1.33M | 5.78M | -278.00K |
| Cash from Operations | -74.82M | -64.84M | -59.93M | -60.93M | -68.64M |
| Capital Expenditure | -1.50M | -545.00K | -18.00K | -120.00K | -555.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 7.00K |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.01M | -2.01M | -- | -- | -- |
| Cash from Investing | -3.51M | -2.56M | -18.00K | -120.00K | -548.00K |
| Total Debt Issued | -- | -- | -- | -- | 8.94M |
| Total Debt Repaid | -10.36M | -11.06M | -11.77M | -2.35M | -1.65M |
| Issuance of Common Stock | 265.89M | 213.89M | 211.94M | 147.46M | 69.44M |
| Repurchase of Common Stock | -5.95M | -5.95M | -3.05M | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -9.05M | -8.29M | -12.51M | -10.24M | 13.69M |
| Cash from Financing | 240.54M | 188.59M | 184.62M | 134.87M | 90.43M |
| Foreign Exchange rate Adjustments | 7.00K | -6.00K | -1.00K | 4.00K | -30.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 162.21M | 121.18M | 124.67M | 73.83M | 21.22M |